Monday, 13 July 2020

Russia's COVID-19 Vaccine Tests Successful on Humans

Six months since the first coronavirus case was reported, we are seeing a Russian contender come out with some positive results. Till now only a Chinese vaccine by CanSino Biological Inc has been approved for use on the military for a period of one year.

Yesterday, the Russian embassy in India tweeted out an update on the vaccine they have been working on. The Sechenov First Moscow State Medical University conducted human trials on a group of a total of 38 volunteers in two batches. It seems that the vaccine has proved to be effective and the volunteers are safe.

This is according to a disclosure made by the director of the Institute for Translational Medicine and Biotechnology Vadim Tarasov.

“Sechenov University has successfully completed tests on volunteers of the world’s first vaccine against coronavirus”., Tarasov said


They will soon be discharged from the facilities in two batches – Wednesday, 15 July and five days after that on Monday, 20 July.

According to Alexander Lukashev, the director of the Institute of Medical Parasitology, Tropical, and Vector-Borne Diseases at Sechenov University, the objective of this stage of the study was to show the vaccine’s safety on humans, which was successfully done.

The safety of the vaccine has been confirmed. It corresponds to the safety of those vaccines that are currently on the market”, Lukashev told Sputnik.

A further vaccine development plan is already being determined by the developer, including the complexity of the epidemiological situation with the virus and the possibility of scaling up production, Lukashev added.

“Sechenov University in a pandemic situation acted not only as an educational institution but also as a scientific and technological research centre that is able to participate in the creation of such important and complex products as drugs … We worked with this vaccine, starting with preclinical studies and protocol development, and clinical trials are currently underway”, Tarasov noted.

No comments:

Post a comment